NCT05814640 Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) Status RECRUITING Phase PHASE1/PHASE2
NCT05705492 Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer Status RECRUITING Phase PHASE2
NCT05676294 The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory Surgery Status COMPLETED Phase PHASE2
NCT05669742 Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients Status RECRUITING Phase PHASE3
NCT05403580 Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer Status WITHDRAWN Phase PHASE3
NCT05346731 Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents Status UNKNOWN Phase PHASE3
NCT05303064 Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder Status RECRUITING Phase PHASE3
NCT05202275 The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs Status UNKNOWN Phase PHASE2
NCT05170919 Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer Status ENROLLING_BY_INVITATION Phase PHASE2
NCT04939090 Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04669132 Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer Status COMPLETED Phase PHASE2
NCT04518319 Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome Status SUSPENDED Phase PHASE2
NCT04503668 Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients Status TERMINATED Phase PHASE3
NCT03960151 Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy Status WITHDRAWN Phase PHASE2